These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 11139841)
1. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors. Proudman RGW; Pupo AS; Baker JG Pharmacol Res Perspect; 2020 Aug; 8(4):e00602. PubMed ID: 32608144 [TBL] [Abstract][Full Text] [Related]
2. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis. Mari A; Antonelli A; Cindolo L; Fusco F; Minervini A; De Nunzio C Ther Adv Urol; 2021; 13():1756287221993283. PubMed ID: 33912246 [TBL] [Abstract][Full Text] [Related]
3. Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Schwinn DA; Roehrborn CG Int J Urol; 2008 Mar; 15(3):193-9. PubMed ID: 18304211 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. Yu ZJ; Yan HL; Xu FH; Chao HC; Deng LH; Xu XD; Huang JB; Zeng T Front Pharmacol; 2020; 11():658. PubMed ID: 32457631 [TBL] [Abstract][Full Text] [Related]
5. Updates in the function and regulation of α Akinaga J; García-Sáinz JA; S Pupo A Br J Pharmacol; 2019 Jul; 176(14):2343-2357. PubMed ID: 30740663 [TBL] [Abstract][Full Text] [Related]
6. The alpha Holanda VAD; Oliveira MC; de Oliveira Torres CI; de Almeida Moura C; Belchior H; da Silva Junior ED; Gavioli EC Behav Brain Res; 2024 Jul; 469():115027. PubMed ID: 38697302 [TBL] [Abstract][Full Text] [Related]
7. Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists. Martin FM; Harris AM; Rowland RG; Conner W; Lane M; Durbin E; Baron AT; Kyprianou N Gene Ther Mol Biol; 2008; 12(2):253-258. PubMed ID: 20717483 [TBL] [Abstract][Full Text] [Related]
8. Factors Considered by Experienced Urologists when Selecting Alpha-Blockers for Patients with Lower Urinary Tract Symptoms or Benign Prostatic Hyperplasia according to Age. Lee H; Lee JH; Choo MS; Cho MC; Son H; Jeong H; Yoo S Urol Int; 2024 May; ():1-8. PubMed ID: 38749410 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis. Huang W; Xue P; Zong H; Zhang Y Br J Clin Pharmacol; 2016 Jan; 81(1):13-22. PubMed ID: 26255996 [TBL] [Abstract][Full Text] [Related]
14. Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors. Zhang W; Ma Z; Li W; Li G; Chen L; Liu Z; Du L; Li M ACS Med Chem Lett; 2015 May; 6(5):502-6. PubMed ID: 26005522 [TBL] [Abstract][Full Text] [Related]
15. Modulation of alpha 1 adrenergic receptors on urinary bladder in rat spinal cord injury model. Lee G; Park H; Park HS; Lee JG Int Neurourol J; 2012 Jun; 16(2):62-8. PubMed ID: 22816046 [TBL] [Abstract][Full Text] [Related]
16. Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia. McKeage K; Plosker GL Drugs; 2002; 62(4):633-53. PubMed ID: 11893233 [TBL] [Abstract][Full Text] [Related]
17. Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia. Forray C; Noble SA Expert Opin Investig Drugs; 1999 Dec; 8(12):2073-2094. PubMed ID: 11139841 [TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacology of alpha1-adrenoceptor antagonists. Martin DJ Eur Urol; 1999; 36 Suppl 1():35-41; discussion 65. PubMed ID: 10393471 [TBL] [Abstract][Full Text] [Related]